The molecular basis of human igg-mediated enhancement of C4b-binding protein recruitment to group a streptococcus

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

Standard

The molecular basis of human igg-mediated enhancement of C4b-binding protein recruitment to group a streptococcus. / Ermert, David; Laabei, Maisem; Weckel, Antonin; Mörgelin, Matthias; Lundqvist, Martin; Björck, Lars; Ram, Sanjay; Linse, Sara; Blom, Anna M.

I: Frontiers in Immunology, Vol. 10, Nr. JUN, 1230, 04.06.2019.

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

Harvard

APA

CBE

MLA

Vancouver

Author

RIS

TY - JOUR

T1 - The molecular basis of human igg-mediated enhancement of C4b-binding protein recruitment to group a streptococcus

AU - Ermert, David

AU - Laabei, Maisem

AU - Weckel, Antonin

AU - Mörgelin, Matthias

AU - Lundqvist, Martin

AU - Björck, Lars

AU - Ram, Sanjay

AU - Linse, Sara

AU - Blom, Anna M.

PY - 2019/6/4

Y1 - 2019/6/4

N2 - Streptococcus pyogenes infects over 700 million people worldwide annually. Immune evasion strategies employed by the bacteria include binding of the complement inhibitors, C4b-binding protein (C4BP) and Factor H in a human-specific manner. We recently showed that human IgG increased C4BP binding to the bacterial surface, which promoted streptococcal immune evasion and increased mortality in mice. We sought to identify how IgG promotes C4BP binding to Protein H, a member of the M protein family. Dimerization of Protein H is pivotal for enhanced binding to human C4BP. First, we illustrated that Protein H, IgG, and C4BP formed a tripartite complex. Second, surface plasmon resonance revealed that Protein H binds IgG solely through Fc, but not Fab domains, and with high affinity (IgG-Protein H: KD = 0.4 nM; IgG-Fc-Protein H: KD ≤1.6 nM). Each IgG binds two Protein H molecules, while up to six molecules of Protein H bind one C4BP molecule. Third, interrupting Protein H dimerization either by raising temperature to 41°C or with a synthetic peptide prevented IgG-Protein H interactions. IgG-Fc fragments or monoclonal human IgG permitted maximal C4BP binding when used at concentrations from 0.1 to 10 mg/ml. In contrast, pooled human IgG enhanced C4BP binding at concentrations up to 1 mg/ml; decreased C4BP binding at 10 mg/ml occurred probably because of Fab-streptococcal interactions at these high IgG concentrations. Taken together, our data show how S. pyogenes exploits human IgG to evade complement and enhance its virulence. Elucidation of this mechanism could aid design of new therapeutics against S. pyogenes.

AB - Streptococcus pyogenes infects over 700 million people worldwide annually. Immune evasion strategies employed by the bacteria include binding of the complement inhibitors, C4b-binding protein (C4BP) and Factor H in a human-specific manner. We recently showed that human IgG increased C4BP binding to the bacterial surface, which promoted streptococcal immune evasion and increased mortality in mice. We sought to identify how IgG promotes C4BP binding to Protein H, a member of the M protein family. Dimerization of Protein H is pivotal for enhanced binding to human C4BP. First, we illustrated that Protein H, IgG, and C4BP formed a tripartite complex. Second, surface plasmon resonance revealed that Protein H binds IgG solely through Fc, but not Fab domains, and with high affinity (IgG-Protein H: KD = 0.4 nM; IgG-Fc-Protein H: KD ≤1.6 nM). Each IgG binds two Protein H molecules, while up to six molecules of Protein H bind one C4BP molecule. Third, interrupting Protein H dimerization either by raising temperature to 41°C or with a synthetic peptide prevented IgG-Protein H interactions. IgG-Fc fragments or monoclonal human IgG permitted maximal C4BP binding when used at concentrations from 0.1 to 10 mg/ml. In contrast, pooled human IgG enhanced C4BP binding at concentrations up to 1 mg/ml; decreased C4BP binding at 10 mg/ml occurred probably because of Fab-streptococcal interactions at these high IgG concentrations. Taken together, our data show how S. pyogenes exploits human IgG to evade complement and enhance its virulence. Elucidation of this mechanism could aid design of new therapeutics against S. pyogenes.

KW - Immunoglobulin G (IgG)

KW - Infectious disease

KW - Protein complex

KW - Protein stability

KW - Protein-protein interaction

KW - Stoichiometry

KW - Streptococcus pyogenes (S. pyogenes)

KW - The complement system

UR - http://www.scopus.com/inward/record.url?scp=85069197539&partnerID=8YFLogxK

U2 - 10.3389/fimmu.2019.01230

DO - 10.3389/fimmu.2019.01230

M3 - Article

VL - 10

JO - Frontiers in Immunology

T2 - Frontiers in Immunology

JF - Frontiers in Immunology

SN - 1664-3224

IS - JUN

M1 - 1230

ER -